New insulin rival takes on diabetes in major trial
Disease control
Recruiting now
This study tests a new long-acting insulin called GZR4 against another insulin (Insulin Icodec) in 300 adults with type 2 diabetes who already use basal insulin. The goal is to see which one controls blood sugar better and causes fewer side effects like low blood sugar. Participa…
Phase: PHASE3 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Disease control
Last updated Apr 26, 2026 20:03 UTC